Kanaike, Megumi
December 2010
Journal of Pharmacy Practice & Research;Dec2010, Vol. 40 Issue 4, p328
Academic Journal
The article discusses several reports regarding oncology research, including one investigating the use of the drug pyridoxine to prevent capecitabine-induced hand-foot syndrome (palmoplantar erythrodysesthesia syndrome or acral erythema), one investigating the use of the recombinant human keratinocyte growth factor, palifermin, to prevent severe oral mucositis, and one comparing the drugs gemcitabine versus fluorouracil in the adjuvant treatment of pancreatic cancer.


Related Articles

  • Journal scan.  // Cancer Nursing Practice;Sep2014, Vol. 13 Issue 7, p13 

    The article presents abstracts related to cancer care including Japanese education scheme about malignant pleural mesothelioma, the American qualitative research about metastatic breast cancer survivorship care, and a study about the benefits of trastuzumab on patients with gastric cancer.

  • What to expect from HER-2 directed therapies in advanced gastric cancer? DANE, Faysal // Marmara Medical Journal;2015 Special Issue, Vol. 28, p11 

    Gastric cancer is the second most common cause of cancer related death worldwide. Over 20% of the advanced gastric cancer are considered to be HER-2 positive. Studies investigating the prognosis of HER-2 positive advanced gastric cancer revealed conflicting results. Trastuzumab, a monoclonal...

  • Trastuzumab (Herceptin).  // Oncology Nurse Advisor;Sep/Oct2014, Vol. 5 Issue 5, p37 

    No abstract available.

  • BECAPLERMIN. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2010, p170 

    The article presents information on becaplermin, a platelet-derived growth factor, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • BECAPLERMIN. GRIFFITH, H. WINTER // Complete Guide to Prescription & Nonprescription Drugs 2012;2011, p172 

    The article presents information on becaplermin, an platelet-derived growth factor for treatment of skin ulcers in diabetics, including its dosage, usage, adverse reactions, side effects, precautions when administering, and possible interaction with other drugs.

  • Duodenal ischemia and upper GI bleeding are dose-limiting toxicities of 24-h continuous intra-arterial pancreatic perfusion of gemcitabine following vascular isolation of the pancreatic head: early results from the Regional Chemotherapy in Locally... Beane, Joal; Griffin, Kayla; Levy, Elliot; Pandalai, Prakash; Wood, Bradford; Abi-Jaoudeh, Nadine; Beresnev, Tatiana; Shutack, Yvonne; Webb, Carole; Avital, Itzhak; Rudloff, Udo // Investigational New Drugs;Feb2015, Vol. 33 Issue 1, p109 

    Background Regional chemotherapy is used successfully in the treatment of both primary and secondary malignancies, in particular of the peritoneal surface and the liver, and is currently explored as an attractive approach for patients with locally advanced pancreatic ductal adenocarcinoma. To...

  • Palifermin and Chlorhexidine Mouthwashes in Prevention of ChemotherapyInduced Mucositis in Children with Acute Lymphocytic Leukemia: a Randomized Controlled Trial. Gholizadeh, Narges; Mehdipoor, Masoumeh; Sajadi, Hasan; Moosavi, Mahdieh-Sadat // Journal of Dentistry (17283426);Dec2016, Vol. 17 Issue 4, p343 

    Statement of the Problem: Over the past three decades, significant improvements have been achieved in the survival of children with cancer. However, the considerable morbidity which occurs as a result of chemotherapy often restricts the treatment intensity. One of the important dose-limiting and...

  • Targeted Therapies for Gastric Cancer. Yoong, Jaclyn; Michael, Michael; Leong, Trevor // Drugs;2011, Vol. 71 Issue 11, p1367 

    Gastric cancer represents one of the most common cancers internationally. Unfortunately the majority of patients still present at an advanced stage, and despite advances in diagnostic and treatment strategies, outcomes still remain poor with high mortality rates despite a decline in incidence....

  • A Phase I Dose-Escalation and Bioequivalence Study of a Trastuzumab Biosimilar in Healthy Male Volunteers. Wisman, Liselijn; Cock, Eduard; Reijers, Joannes; Kamerling, Ingrid; Os, Sandra; Kam, Marieke; Burggraaf, Jacobus; Voortman, Gerrit // Clinical Drug Investigation;Dec2014, Vol. 34 Issue 12, p887 

    Background: Trastuzumab (Herceptin) is a humanized monoclonal antibody targeting the human epidermal growth factor receptor 2 (HER2) and is used in the treatment of HER2-overexpressing breast and gastric cancer. FTMB is being developed as a biosimilar of trastuzumab. Objective: In this combined...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics